Gastric cancer in Ukraine: epidemiologic data and its nosological structure between 2003 and 2020

Yevgen O. Chernov; Valeriia Haysanovska; Olha V. Makarenko

doi:10.5114/pg.2024.134840

eISSN: 1897-4317
ISSN: 1895-5770

Gastroenterology Review/Przegląd Gastroenterologiczny

Bieżący numer Archiwum Artykuły zaakceptowane O czasopiśmie Rada naukowa Bazy indeksacyjne Prenumerata Kontakt Zasady publikacji prac Opłaty publikacyjne

Panel Redakcyjny

Zgłaszanie i recenzowanie prac online

NOWOŚĆ

Portal dla gastroenterologów!

www.egastroenterologia.pl

Wyszukiwanie

Zasady redakcyjne

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Otwarty dostęp

4/2024
vol. 19

Poleć ten artykuł:

Wyślij znajomemu

Skopiuj link:

Udostępnij:

Artykuł oryginalny

Gastric cancer in Ukraine: epidemiologic data and its nosological structure between 2003 and 2020

Yevgen O. Chernov

¹

,

Valeriia Haysanovska

²

,

Olha V. Makarenko

¹

Department of Social Medicine, Public Health and Health Care Management, Dnipro State Medical University, Dnipro, Ukraine
Department of Laboratory Medicine, Lund University, Lund, Sweden

Gastroenterology Rev 2024; 19 (4): 428–433

DOI: https://doi.org/10.5114/pg.2024.134840

Data publikacji online: 2024/02/02

Plik artykułu:

- Gastric cancer (1).pdf [0.12 MB]

Pobierz cytowanie

Metryki PlumX:

1. Machlowska J, Baj J, Sitarz M, et al. Gastric cancer: Epidemiology, risk factors, classification, genomic characteristics and treatment strategies. Int J Mol Sci 2020; 21: 4012.

2. World Health Organization. International classification of diseases for oncology (ICD-O), 3rd ed., 1st revision. World Health Organization, Malta 2013.

3. World Health Organization. International Classification of Diseases (ICD). https://www.who.int/standards/classifications/classification-of-diseases. Accessed 30 May 2023.

4. Nagtegaal ID, Odze RD, Klimstra D, et al. The 2019 WHO classification of tumours of the digestive system. Histopathology 2020; 76: 182-8.

5. Karimi P, Islami F, Anandasabapathy S, et al. Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev 2014; 23: 700-13.

6. National Cancer Registry of Ukraine: Short description of the database. Cancer in Ukraine. Ukrainian cancer registry statistics, bulletin of national cancer registry of Ukraine – No 4–20. [Elektronnyiy resurs].

7. Association of pathologists of Ukraine. Practical diagnosis. Methodological recommendations for the pathomorphological diagnosis. [Практична діагностика. Методичні рекомендації з патоморфологічної діагностики.] (patholog.org.ua). Accessed 23rd of May 2023.

8. Governmental portal. Official website. Ministry of health introduces international standards for pathomorphological diagnosis | The Cabinet of Ministers of Ukraine [МОЗ запроваджує міжнародні стандарти патологоанатомічної діагностики | Кабінет Міністрів України] (kmu.gov.ua). Accessed 23rd of May 2023.

9. Oliveira C, Seruca R, Carneiro F. Genetics, pathology, and clinics of familial gastric cancer. Int J Surg Pathol 2006; 14: 21-33.

10. Moskalenko YV, Vynnychenko IO, Moskalenko RA, et al. Clinical oncology: manual. Sumy state university, Sumy 2020 [Клінічна онкологія : навч. посіб. / Ю. В. Москаленко, І. О. Винниченко, Р. А. Москаленко та ін. ; за ред. Ю. В. Москаленко. – Суми : Сумський державний університет, 2020. – 212 с.].

11. Segna D, Brusselaers N, Glaus D, et al. Association between proton-pump inhibitors and the risk of gastric cancer: a systematic review with meta-analysis. Therap Adv Gastroenterol 2021; 14: 17562848211051463.

12. Hálfdánarson ÓÖ, Pottegård A, Björnsson ES, et al. Proton-pump inhibitors among adults: a nationwide drug-utilization study. Therap Adv Gastroenterol 2018; 11: 1756284818777943.

13. Bugaytsova JA, Björnham O, Chernov YA, et al. Helicobacter pylori adapts to chronic infection and gastric disease via pH-responsive babA-mediated adherence. Cell Host Microbe 2017; 21: 376-89.

14. Malfertheiner P, Megraud F, O’Morain CA, et al. Management of Helicobacter pylori infection-the Maastricht V/Florence consensus report. Gut 2017; 66: 6-30.

15. Iwamoto J, Mizokami Y, Takahashi K, et al. The effects of cyclooxygenase2-prostaglandinE2 pathway on Helicobacter pylori-induced urokinase-type plasminogen activator system in the gastric cancer cells. Helicobacter 2008; 13: 174-82.

16. Moonens K, Gideonsson P, Subedi S, et al. Structural insights into polymorphic ABO glycan binding by Helicobacter pylori. Cell Host Microbe 2016; 19: 55-66.

Copyright: © 2024 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.

Gastric cancer in Ukraine: epidemiologic data and its nosological structure between 2003 and 2020

Yevgen O. Chernov 1 , Valeriia Haysanovska 2 , Olha V. Makarenko 1

Yevgen O. Chernov

¹

,

Valeriia Haysanovska

²

,

Olha V. Makarenko

¹